First Report of Real World Utilization of an Activin Signaling Inhibitor in Patients With Severe Pulmonary Arterial Hypertension in the Middle East PH RISE-ME Study.
Jabi MA, Sabbour H, Mohamed L, Alsultan S, Almassabi M, Osama M, Abudouleh A, Sondoqah M, Zaki MK, Hesham A, Saleh KM, Haque MUI, Preston I
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.